VR Logo

Adamis Pharmaceuticals Corporation (ADMP) download report


Healthcare | Drugs & Pharma

Adamis Pharmaceuticals Corporation (ADMP) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States.

IPO Date: 14-Aug-1995

Co-Founder, CEO, Pres & Director: Mr. David J. Marguglio

Chief Medical Officer: Dr. Ronald B. Moss M.D.

Listing: NASDAQ: ADMP

Country: United States

Headquarters: San Diego, CA

Website: https://www.adamispharmaceuticals.com

Key Facts

Market cap: $56.09 Mln

Revenue (TTM): $8.02 Mln

Earnings (TTM): $-37.76 Mln

Cash: $17.77 Mln

Total Debt: $2.46 Mln

Insider's Holding: 1.07%

Liquidity: Low

52 Week range: $0.31 - 1.48

Shares outstanding: 149,983,008

10 Years Aggregate:

  • CFO: $-169.39 Mln
  • EBITDA: $-222.71 Mln
  • Net Profit: $-245.79 Mln

Stock Performance

Time Period Adamis Pharmaceuticals (ADMP) S&P BSE Healthcare* S&P Small-Cap 600*
YTD-38.69-11.25-11.58
1 month-25.205.368.86
3 months-15.001.49-2.19
1 Year-63.69-11.80-6.23
3 Years-27.2222.769.73
5 Years-39.4610.867.72
10 Years-28.3912.2710.81
As on 05-Aug-2022 *As on 08-Aug-2022
Year Adamis Pharmaceuticals (ADMP) S&P Small-Cap 600 S&P BSE Healthcare
202125.7525.2720.87
2020-30.749.5761.45
2019-68.8720.86-3.55
2018-48.68-9.70-5.89
201739.6811.730.49
2016-41.6724.74-12.88
2015-12.48-3.3615.06